urea has been researched along with Granulocytic Leukemia, Chronic in 7 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Takeda, T | 1 |
| Tsubaki, M | 1 |
| Genno, S | 1 |
| Nemoto, C | 1 |
| Onishi, Y | 1 |
| Yamamoto, Y | 1 |
| Imano, M | 1 |
| Satou, T | 1 |
| Nishida, S | 1 |
| Lei, H | 1 |
| Jin, J | 1 |
| Liu, M | 1 |
| Li, X | 1 |
| Luo, H | 1 |
| Yang, L | 1 |
| Xu, H | 1 |
| Wu, Y | 1 |
| Yun, SM | 1 |
| Jung, KH | 2 |
| Kim, SJ | 2 |
| Fang, Z | 2 |
| Son, MK | 2 |
| Yan, HH | 2 |
| Lee, H | 2 |
| Kim, J | 2 |
| Shin, S | 1 |
| Hong, S | 2 |
| Hong, SS | 2 |
| Ryu, YL | 1 |
| Lim, JH | 1 |
| Suh, JK | 1 |
| Lee, S | 1 |
| Tanaka, R | 1 |
| Squires, MS | 1 |
| Kimura, S | 1 |
| Yokota, A | 1 |
| Nagao, R | 1 |
| Yamauchi, T | 1 |
| Takeuchi, M | 1 |
| Yao, H | 1 |
| Reule, M | 1 |
| Smyth, T | 1 |
| Lyons, JF | 1 |
| Thompson, NT | 1 |
| Ashihara, E | 1 |
| Ottmann, OG | 1 |
| Maekawa, T | 1 |
| Shah, M | 1 |
| Gallipoli, P | 1 |
| Lyons, J | 1 |
| Holyoake, T | 1 |
| Jørgensen, H | 1 |
| WEISS, HJ | 1 |
7 other studies available for urea and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
AT9283 exhibits antiproliferative effect on tyrosine kinase inhibitor‑sensitive and ‑resistant chronic myeloid leukemia cells by inhibition of Aurora A and Aurora B.
Topics: Aurora Kinase A; Aurora Kinase B; Benzimidazoles; Cell Line, Tumor; Cell Survival; Drug Resistance, | 2020 |
Chk1 inhibitors overcome imatinib resistance in chronic myeloid leukemia cells.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 1; Drug Resistance, Neop | 2018 |
HS-438, a new inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Benzothiazoles; Binding Sites; Cell Cycle Che | 2014 |
HS-543 induces apoptosis of Imatinib-resistant chronic myelogenous leukemia with T315I mutation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Ne | 2015 |
Activity of the multitargeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL-positive leukemic cells.
Topics: Animals; Antineoplastic Agents; Benzamides; Benzimidazoles; Cell Proliferation; Drug Delivery System | 2010 |
Effects of the novel aurora kinase/JAK inhibitor, AT9283 and imatinib on Philadelphia positive cells in vitro.
Topics: Antineoplastic Agents; Aurora Kinases; Benzamides; Benzimidazoles; Cell Line, Tumor; Cell Survival; | 2012 |
INCREASED UREA SOLUBILITY OF THE BLOOD CLOT IN CHRONIC GRANULOCYTIC LEUKEMIA AND ITS RELATION TO THE ABNORMAL THROMBELASTOGRAM.
Topics: Blood Coagulation; Chemical Phenomena; Chemistry; Humans; Leukemia; Leukemia, Myelogenous, Chronic, | 1963 |